海峡药学2024,Vol.36Issue(8) :48-52.

基于HPLC-DAD数据库快速筛查降血脂类产品中非法添加的10种化学药物

Rapid Screening of Ten Hypolipidemic Drugs Illegally Added in Products Based on a HPLC-DAD Database

张萍 汤慧 李文斌 徐莹
海峡药学2024,Vol.36Issue(8) :48-52.

基于HPLC-DAD数据库快速筛查降血脂类产品中非法添加的10种化学药物

Rapid Screening of Ten Hypolipidemic Drugs Illegally Added in Products Based on a HPLC-DAD Database

张萍 1汤慧 1李文斌 2徐莹2
扫码查看

作者信息

  • 1. 芜湖市食品药品检验中心,安徽芜湖 241006
  • 2. 天津迪科马实验设备有限公司,天津 300499
  • 折叠

摘要

目的 建立一种能同时检测10种有降血脂作用化学药物的HPLC-DAD分析方法,建立各物质保留时间和紫外吸收光谱的二维定性数据库,并将此数据库用于降血脂药物非法添加的快速筛查.方法 采用迪马Platisil ODS色谱柱;以0.5%甲酸为流动相A,以乙腈为流动性B,进行梯度洗脱.采集HPLC-DAD检测结果中的对照品的保留时间紫外吸收光谱信息,建立10种常见降血脂化学药物的二维定性数据库.结果 本实验基于HPLC-DAD方法新建立了 一个快速筛查降血脂类产品中非法添加的数据库,通过对市场抽检样品和模拟阳性样品的检测,结果准确可靠.结论 本实验建立的HPLC-DAD数据库可快速筛查产品中是否添加了降血脂类化学药物,具有操作简便、快速的特点,为基层监督检验机构提供了一个可靠的方法学参考.

Abstract

OBJECTIVE To establish a HPLC-DAD analysis method for simultaneous determination of ten hy-polipidemic drugs,and a two-dimensional qualitative database was established based on the retention time and ultra-violet absorption spectrum of various substances.This database was used for rapid screening of illegal addition in hy-polipidemic products.METHODS The gradient elution was used with 0.5%formic acid as mobile phase A and acetonitrile as mobile phase B.The retention time and ultraviolet absorption spectra of 10 reference materials were collected,and a two-dimensional qualitative database was established on this basis.RESULTS Based on the HPLC-DAD method,a new database for rapid screening of illegal addition of lipid-lowering products was established in this experiment.The results were accurate and reliable through the detection of market sampling samples and simulated positive samples.CONCLUSION The HPLC-DAD database established in this experiment can quickly screen the illegally added chemical drugs in products.This method is simple and fast,and provides a reliable methodological ref-erence for the basic inspection institutions.

关键词

HPLC-DAD数据库/降血脂药物/非法添加

Key words

HPLC-DAD database/Hypolipidemic drugs/Illegal addition

引用本文复制引用

基金项目

安徽省药品监督管理局科技创新项目(AHYJ-KJ-202012)

芜湖市科技计划项目(2022JC05)

出版年

2024
海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
段落导航相关论文